AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 108 filers reported holding AVROBIO INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $218,000 | -25.3% | 16,716 | 0.0% | 0.00% | – |
| Q2 2020 | $292,000 | +12.3% | 16,716 | 0.0% | 0.00% | – |
| Q1 2020 | $260,000 | -7.8% | 16,716 | +19.3% | 0.00% | – |
| Q4 2019 | $282,000 | +16.0% | 14,017 | -18.5% | 0.00% | – |
| Q3 2019 | $243,000 | +3.0% | 17,206 | +18.6% | 0.00% | – |
| Q2 2019 | $236,000 | -29.1% | 14,504 | -4.0% | 0.00% | -100.0% |
| Q1 2019 | $333,000 | +14.4% | 15,104 | -13.7% | 0.00% | 0.0% |
| Q4 2018 | $291,000 | -68.0% | 17,504 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $908,000 | +318.4% | 17,504 | +130.2% | 0.00% | – |
| Q2 2018 | $217,000 | – | 7,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |